| Literature DB >> 26649083 |
Pavol Klobusicky1, David Hoskovec2.
Abstract
INTRODUCTION: The role of fixation of the mesh is especially important in the endoscopic technique. The fixation of mesh through penetrating techniques using staples, clips or screws is associated with a significantly increased risk of developing a post-herniotomy pain syndrome. AIM: To demonstrate the safety and efficacy of the self-fixating anatomical Parietex ProGrip laparoscopic mesh (Sofradim Production, Trévoux France) used with laparoscopic transabdominal preperitoneal hernia repair. The incidence of chronic post-herniotomy pain and recurrence rate in the follow-up after 12 months were evaluated.Entities:
Keywords: Herniamed; ProGrip laparoscopic mesh; laparoscopic inguinal hernia repair; transabdominal preperitoneal
Year: 2015 PMID: 26649083 PMCID: PMC4653269 DOI: 10.5114/wiitm.2015.54222
Source DB: PubMed Journal: Wideochir Inne Tech Maloinwazyjne ISSN: 1895-4588 Impact factor: 1.195
Inclusion and exclusion criteria
| Inclusion criteria: |
| Age > 18 years |
| Patients operated on with TAPP technique for inguinal hernia using Parietex ProGrip laparoscopic mesh, without additional fixation, between May 2013 and December 2014 |
| Patients successfully and completely documented in online database Herniamed |
| Exclusion criteria: |
| Age < 18 years |
| Scrotal/large hernia with defect > 4 cm |
| Patients with incarcerated hernia needing emergency surgery |
| Patients with ASA IV or patients who could not be operated on under general anesthesia for other reasons |
Photo 1Anatomical self gripping Parietex ProGrip laparoscopic mesh
Photo 4Running suture of peritoneum
Demographic and preoperative data (n = 95)
| Demographic and preoperative data | Number of patients | Percent or range |
|---|---|---|
| Gender: | ||
| Male | 85 | 89.47 |
| Female | 10 | 10.53 |
| BMI, mean [kg/m2] | 28.2 | 19.9–43.3 |
| ASA class: | ||
| I | 38 | 40.00 |
| II | 49 | 51.58 |
| III | 8 | 8.42 |
| IV | 0 | 0.00 |
| Main co-morbidities (minimum 1 comorbidity): | 22 | 23.16 |
| COPD/bronchial asthma | 1 | 1.05 |
| Diabetes mellitus | 4 | 4.21 |
| Aortal aneurysm | 0 | 0.00 |
| Immunosuppression | 0 | 0.00 |
| Cortisone | 0 | 0.00 |
| Nicotine overuse | 9 | 9.47 |
| Coagulation disorders | 0 | 0.00 |
| Drugs that prevent aggregation of thrombocytes, withdrawn < 7 days ago | 13 | 13.68 |
| Coumarin derivates (Quick/INR in non-physiological range) | 0 | 0.00 |
| Previous abdominal surgery | 49 | 51.57 |
Perioperative data and hernia details during operation (n = 95)
| Perioperative data | Results | |
|---|---|---|
| Elective surgery | 95 | 100% |
| Number of hernias: | 156 | |
| Unilateral hernia: | 34 | 35.79% |
| Right sided | 20 | |
| Left sided | 14 | |
| Bilateral hernias | 61 | 64.21% |
| Recurrent hernias | 32 | 20.51% |
| Average time of surgery [min]: | 64 | 27–127 |
| Unilateral hernia | 58 | 27–88 |
| Bilateral hernia | 67 | 45–127 |
| EHS classification: | Right sided hernia 51.92% | Left sided hernia 48.08% |
| Medial | 50 (61.73%) | 41 (54.67%) |
| Lateral | 27 (33.33%) | 32 (42.67%) |
| Femoral | 2 (2.47%) | 1 (1.33%) |
| Scrotal | 2 (2.47%) | 1 (1.33%) |
| Size of hernia opening: | Right sided | Left sided |
| < 1.5 cm, 13 (8.33%) | 9 | 4 |
| 1.5–3 cm, 105 (67.31%) | 55 | 50 |
| > 3 cm, 38 (24.36%) | 17 | 21 |
Complications
| Postoperative major complications related to the surgical procedure |
| 1.05% |
|---|---|---|
| Postoperative hemorrhage in the area of the groin extraperitoneally | 0 | 0.00% |
| Secondary intraperitoneal bleeding on trocar side | 1 | 1.05% |
| Postoperative mechanical ileus | 0 | 0.00% |
|
|
|
|
| Seroma | 1 | 1.05% |
| Hematoma in abdominal wall | 1 | 1.05% |
| Hematuria | 0 | 0.00% |
Patient-reported pain using VAS scale prior to surgery and each follow-up evaluation
| VAS scale | Before surgery ( | D1 ( | M1 ( | Y1 ( |
|---|---|---|---|---|
| None (VAS 0) | 34 (35.79) | 14 (14.74) | 82 (86.32) | 55 (96.49) |
| Mild (VAS 1–3) | 45 (47.37) | 76 (80.00) | 13 (13.68) | 2 (3.51) |
| Moderate (VAS 4–6) | 16 (16.84) | 5 (5.26) | 1 (1.05) | 0 (0.00) |
| Severe (VAS > 6) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) |
Analysis of chronic pain after 1 year (Y1) (n = 57 (57/95))
| VAS scale | Y1, |
|---|---|
| None (VAS 0) | 55 (96.49) |
| Mild (VAS 1–3) | 2 (3.51) |
| Moderate (VAS 4–6) | 0 (0.00) |
| Severe (VAS > 6) | 0 (0.00) |